Evidence map›Paper›PMID 39091578›Full record

ArticleJournal of medical cases2024

Synchronous Double Primary Lung Adenocarcinomas With

Seijitsu Ando, Shinji Futami, Koji Azuma, Kanako Nishimatsu, Takuma Shirasaka, Seigo Minami

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seijitsu AndoDepartment of Respiratory Medicine, NHO Osaka National Hospital, Osaka City, Osaka 540-0006, Japan.
Shinji FutamiDepartment of Respiratory Medicine, NHO Osaka National Hospital, Osaka City, Osaka 540-0006, Japan.
Koji AzumaDepartment of Respiratory Medicine, NHO Osaka National Hospital, Osaka City, Osaka 540-0006, Japan.
Kanako NishimatsuDepartment of Respiratory Medicine, NHO Osaka National Hospital, Osaka City, Osaka 540-0006, Japan.
Takuma ShirasakaAIDS Medical Center, NHO Osaka National Hospital, Osaka City, Osaka 540-0006, Japan.
Seigo MinamiDepartment of Respiratory Medicine, NHO Osaka National Hospital, Osaka City, Osaka 540-0006, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various driver mutations and the corresponding molecular-targeted drugs have been detected and developed in non-small cell lung cancer. There were many cases in which surgical specimens had happened to find double primary cancers. However, to our knowledge, our case was the first report of synchronous double primary lung adenocarcinomas harboring epidermal growth factor receptor (

Indexed as

AdenocarcinomaCapmatinibEGFR L858R point mutationMET exon 14 skipping mutationMultiple primary lung cancersOsimertinibSynchronous double primary lung cancers

Identifiers

PMID39091578
PMCPMC11287901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.